Ameriprise
VIVO

Ameriprise’s Meridian Bioscience Inc VIVO Stock Holding History

Ameriprise’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-224,041
Closed -$7.44M – 4082
2022
Q4 		$7.44M Sell
224,041
-9,211
-4% -$297K ﹤0.01% 2002
2022
Q3 		$7.36M Sell
233,252
-2,162
-0.9% -$70K ﹤0.01% 1940
2022
Q2 		$7.16M Buy
235,414
+5,046
+2% +$136K ﹤0.01% 2018
2022
Q1 		$5.98M Sell
230,368
-4,225
-2% -$100K ﹤0.01% 2307
2021
Q4 		$4.79M Buy
234,593
+4,014
+2% +$77K ﹤0.01% 2488
2021
Q3 		$4.44M Sell
230,579
-10,729
-4% -$214K ﹤0.01% 2470
2021
Q2 		$5.35M Sell
241,308
-11,255
-4% -$239K ﹤0.01% 2407
2021
Q1 		$6.63M Buy
252,563
+21,751
+9% +$517K ﹤0.01% 2207
2020
Q4 		$4.31M Sell
230,812
-21,002
-8% -$392K ﹤0.01% 2371
2020
Q3 		$4.28M Sell
251,814
-1,433
-0.6% -$27.9K ﹤0.01% 2196
2020
Q2 		$5.9M Sell
253,247
-8,709
-3% -$126K ﹤0.01% 1943
2020
Q1 		$2.2M Sell
261,956
-227,197
-46% -$1.91M ﹤0.01% 2419
2019
Q4 		$4.78M Sell
489,153
-4,878
-1% -$45.8K ﹤0.01% 2261
2019
Q3 		$4.69M Sell
494,031
-208,645
-30% -$2.2M ﹤0.01% 2245
2019
Q2 		$8.35M Buy
702,676
+207,104
+42% +$2.49M ﹤0.01% 1874
2019
Q1 		$8.73M Buy
495,572
+100,506
+25% +$1.67M ﹤0.01% 1812
2018
Q4 		$6.86M Sell
395,066
-13,129
-3% -$224K ﹤0.01% 1902
2018
Q3 		$6.08M Buy
408,195
+43,264
+12% +$671K ﹤0.01% 2214
2018
Q2 		$5.8M Buy
364,931
+99,282
+37% +$1.48M ﹤0.01% 2142
2018
Q1 		$3.77M Buy
265,649
+4,284
+2% +$63.4K ﹤0.01% 2371
2017
Q4 		$3.66M Sell
261,365
-2,309
-0.9% -$33.8K ﹤0.01% 2332
2017
Q3 		$3.77M Sell
263,674
-3,883
-1% -$55.5K ﹤0.01% 2283
2017
Q2 		$4.21M Buy
267,557
+28,488
+12% +$410K ﹤0.01% 2202
2017
Q1 		$3.3M Buy
239,069
+10,138
+4% +$142K ﹤0.01% 2315
2016
Q4 		$4.05M Buy
228,931
+9,964
+5% +$175K ﹤0.01% 2205
2016
Q3 		$4.22M Buy
218,967
+8,687
+4% +$170K ﹤0.01% 2114
2016
Q2 		$4.1M Buy
210,280
+7,285
+4% +$143K ﹤0.01% 2088
2016
Q1 		$4.18M Sell
202,995
-865
-0.4% -$17K ﹤0.01% 2086
2015
Q4 		$4.18M Buy
203,860
+931
+0.5% +$17.8K ﹤0.01% 2153
2015
Q3 		$3.47M Buy
202,929
+303
+0.1% +$5.54K ﹤0.01% 2263
2015
Q2 		$3.78M Buy
202,626
+4,332
+2% +$80.3K ﹤0.01% 2334
2015
Q1 		$3.78M Buy
198,294
+9,862
+5% +$182K ﹤0.01% 2242
2014
Q4 		$3.1M Buy
188,432
+5,799
+3% +$99.5K ﹤0.01% 2344
2014
Q3 		$3.23M Sell
182,633
-71,371
-28% -$1.4M ﹤0.01% 2286
2014
Q2 		$5.24M Buy
254,004
+6,927
+3% +$142K ﹤0.01% 2046
2014
Q1 		$5.38M Sell
247,077
-143,483
-37% -$3.29M ﹤0.01% 1968
2013
Q4 		$10.4M Buy
390,560
+16,135
+4% +$397K 0.01% 1467
2013
Q3 		$8.86M Sell
374,425
-85,213
-19% -$1.99M 0.01% 1551
2013
Q2 		$9.88M Buy
+459,638
New +$9.91M 0.01% 1436

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameriprise's VIVO Position: Q1 2023 in Review

Ameriprise sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 224,041 shares — an estimated $7.44M sold.

Ameriprise first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $10.4M in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Ameriprise reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Ameriprise sold 224,041 Meridian Bioscience Inc shares in Q1 2023, an estimated $7.44M.
  • Ameriprise first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Ameriprise's Meridian Bioscience Inc position peaked at $10.4M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.